Literature DB >> 15297214

Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review.

Olivier Picone1, Catherine Lhommé, Michel Tournaire, Patricia Pautier, Sophie Camatte, Marie-Cecile Vacher-Lavenue, Damienne Castaigne, Philippe Morice.   

Abstract

BACKGROUND: To report a case of successful management of a FIGO stage III endometrioid carcinoma of the ovary diagnosed during pregnancy at 22 weeks of gestation and treated with initial chemotherapy while preserving the pregnancy. CASE: The patient underwent a planned cesarean section at 34 weeks after two courses of carboplatin. She delivered a healthy baby. At the same time, a radical hysterectomy, omentectomy, pelvic and paraaortic lymphadenectomies and peritonectomies were carried out. The surgical resection was complete (no macroscopic residual disease). During histologic examination, traces of persistent disease were found. The patient underwent seven postoperative courses of chemotherapy (carboplatin + paclitaxel regimen) after radical surgery. After 18 months of follow-up posttreatment, the patient remains in complete remission and the child's development is normal.
CONCLUSION: Chemotherapy during pregnancy with preservation of the fetus could be considered and should be discussed in case of epithelial ovarian cancer (EOC) diagnosed during the second trimester of the pregnancy.

Entities:  

Mesh:

Year:  2004        PMID: 15297214     DOI: 10.1016/j.ygyno.2004.05.030

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

Review 1.  Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature.

Authors:  Esra Tonguc; Tayfun Güngor; Turgut Var; Mustafa Ozat; Izzet Sahin; Levent Sirvan
Journal:  Arch Gynecol Obstet       Date:  2010-08-29       Impact factor: 2.344

Review 2.  Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature.

Authors:  Krystyna Serkies; Ewa Węgrzynowicz; Jacek Jassem
Journal:  Arch Gynecol Obstet       Date:  2011-03-03       Impact factor: 2.344

3.  Outcomes of planned delivery delay in pregnant patients with invasive gynecologic cancer.

Authors:  Shin-ichi Ishioka; Yoshiaki Ezaka; Toshiaki Endo; Kunihiko Nagasawa; Ayumi Shimizu; Akiyasu Sato; Marie Inoue; Tsuyoshi Saito
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

4.  Advanced epithelial ovarian carcinoma during pregnancy.

Authors:  Shin-ichi Ishioka; Takuhiro Hayashi; Toshiaki Endo; Tsuyoshi Baba; Hiroyuki Honma; Tsuyoshi Saito
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

5.  Ovarian Cancer During Pregnancy: A Case Report and Literature Review.

Authors:  Moawia E Hummeida; Kamal Hamad; Abdel Fatah Abdel Gadir; AbdelAziem A Ali
Journal:  Clin Pract       Date:  2015-06-29

Review 6.  Therapeutic management of epithelial ovarian cancer during pregnancy.

Authors:  L Minig; L Otaño; I Diaz-Padilla; R Alvarez Gallego; M G Patrono; J Valero de Bernabé
Journal:  Clin Transl Oncol       Date:  2012-11-21       Impact factor: 3.405

Review 7.  Does Chemotherapy for Gynecological Malignancies during Pregnancy Cause Fetal Growth Restriction?

Authors:  Nabil Abdalla; Magdalena Bizoń; Robert Piórkowski; Paweł Stanirowski; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  Biomed Res Int       Date:  2017-05-24       Impact factor: 3.411

Review 8.  Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety.

Authors:  Christina N Cordeiro; Mary L Gemignani
Journal:  Obstet Gynecol Surv       Date:  2017-03       Impact factor: 2.347

Review 9.  Gynecologic malignancy in pregnancy.

Authors:  Yong Il Ji; Ki Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2013-09-14

Review 10.  Cancer treatment in pregnant women.

Authors:  Pawel Basta; Anna Bak; Krzysztof Roszkowski
Journal:  Contemp Oncol (Pozn)       Date:  2014-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.